Publication | Closed Access
Inhibition of Angiotensin-Converting Enzyme by Quercetin Alters the Vascular Response to Bradykinin and Angiotensin I
110
Citations
19
References
2002
Year
Quercetin AltersHypertensionVascular ResponseDistributed FlavonoidsVascular PharmacologyPhysiologyPharmacologyCardiovascular PharmacologyAngiotensin-converting EnzymeEndothelial DysfunctionHerb-drug InteractionPhytopharmacologyVascular BiologyPharmacotherapyQuercetin PretreatmentMedicinePlant KingdomDrug Discovery
Quercetin, one of the most widely distributed flavonoids in the plant kingdom, inhibits various enzymes. This study examined its inhibitory effect on the angiotensin-converting enzyme activity through the cardiovascular response to bradykinin and angiotensin I. Quercetin pre-treatment (88.7 micromol/kg p.o., 45 min; 14.7 micromol/kg i.v., 5 min) significantly potentiated the hypotensive effect of bradykinin (10 nmol/kg i.v.). This association was significantly attenuated by an antagonist of the B2 receptor. In addition, the hypertensive response to angiotensin I (0.1 nmol/kg i.v.) was significantly reduced by quercetin pretreatment using the same parameters as before. These results suggest an inhibitory effect of quercetin on the angiotensin-converting enzyme activity, similar to that of captopril. Quercetin was equally effective when given orally or intravenously.
| Year | Citations | |
|---|---|---|
Page 1
Page 1